Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, has received the Priority Review designation from US Food and Drug... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75528&sid=2Global Study Advances Upsher-Smith's CNS Pipeline PR Newswire MAPLE GROVE, Minn., May 22, 2013 /PRNewswire/ --Upsher-Smith Laboratories, Inc. today... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=46062&title=UpsherSmith-Successfully-Completes-Phase-III-Study-Of-USL255-ExtendedRelease-Topiramate-For-Adjunctive-Treatment-Of-Epilepsy-In-Patients-With-Refractory-PartialOnset-SeizuresFor MOXDUO® Advisory Committee Meeting SYDNEY and BEDMINSTER, N.J., May 17, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY)... ...
http://www.andhranews.net/Intl/Web/2-38.asp(GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310077/PRNewswire/ --Actavis, Inc. (NYSE: ACT) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Actavis' New Drug... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=44944